Involving 222 NC adults over 11 years, those in stage 2 (low Aβ, high tau/p-tau) showed markedly lower baseline scores and greater cognitive impairment, suggesting that abnormal amyloid and tau levels are necessary for cognitive differences in NC individuals. This evidence concerns the gene MAPT and Cognitive impairment.